United States · FDA National Drug Code directory
Spironolactone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-6369_5cfdfcdf-5472-4384-a651-b8d4f65a19f7
- Product NDC
- 50090-6369
- Form
- TABLET, COATED
- Composition / generic term
- Spironolactone
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210104
- Source listing expiry
- 20261231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, COATED in 1 BOTTLE (50090-6369-0) · 50090-6369-0
- 30 TABLET, COATED in 1 BOTTLE (50090-6369-1) · 50090-6369-1
- 90 TABLET, COATED in 1 BOTTLE (50090-6369-6) · 50090-6369-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →